Category-theoretic graph rewriting with DPO, SPO, and SqPO pushouts for C-Sets. Declarative transformation of acset data structures.
日本語の概要は準備中です。原文の説明を表示しています。
63 件 ・ 関連度順
概要と使いどころ
Category-theoretic graph rewriting with DPO, SPO, and SqPO pushouts for C-Sets. Declarative transformation of acset data structures.
日本語の概要は準備中です。原文の説明を表示しています。
Use when diagnosing NPU + PyTorch or LLM Serving Host CPU affinity, NUMA locality, cgroup/cpuset constraints, CPU range conflicts, PyTorch/runtime threading, DataLoader, tokenizer, scheduler, vLLM-Ascend, SGLang, TTFT, TPOT, tokens/s, QPS, or multi-rank/multi-worker CPU binding issues.
日本語の概要は準備中です。原文の説明を表示しています。
Creates high-converting 'X vs Y' and 'X alternatives' SEO pages that capture comparison search traffic. Researches competitors, writes honest comparison content, and adds schema markup (FAQPage, ItemList). Use when someone needs alternatives pages, comparison content, or says 'alternatives page', 'vs page', 'comparison', 'competitor alternatives', 'X vs Y page', or wants to capture competitor brand search traffic with SEO content. Also trigger when someone wants to rank for competitor brand names, capture competitor search traffic, create a compare page, or build a competitive content hub. Even if they just say 'how do we compete with X' or 'we need to show up when people search for [competitor]', this skill applies. Owns the individual alternatives / vs / comparison page. For a batch roadmap of many pages with a phase tracker, see /seo-machine. For programmatic SEO and templated content at scale, see /seo-content.
日本語の概要は準備中です。原文の説明を表示しています。
Spring Modulith 2.0 implementation for bounded contexts in Spring Boot 4. Use when structuring application modules, implementing @ApplicationModuleListener for event-driven communication, testing with Scenario API, enforcing module boundaries, externalizing events to Kafka/AMQP, building a modular monolith, defining module dependencies, managing inter-module events, or organizing DDD modules as packages. Covers package-based module boundaries, named interfaces, event publication, and Scenario API testing. For architecture decisions, see domain-driven-design skill.
日本語の概要は準備中です。原文の説明を表示しています。
Generate complete JSON-LD schema markup for blog posts with Article/BlogPosting, Person, Organization, BreadcrumbList, ImageObject, and optional FAQPage. Validates against Google requirements and warns about deprecated types. Use when user says "schema", "blog schema", "json-ld", "structured data", "schema markup", "generate schema".
日本語の概要は準備中です。原文の説明を表示しています。
Auto-activate for litestar_saq, SAQPlugin, SAQConfig, QueueConfig, TaskQueues, CronJob, litestar workers run, background jobs, schedules, or SAQ UI. Not for litestar-queues, Celery, RQ, or Dramatiq.
日本語の概要は準備中です。原文の説明を表示しています。
Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.
日本語の概要は準備中です。原文の説明を表示しています。
Plan, execute, and document validation, verification, and transfer of analytical procedures under the governing framework - ICH Q2(R2) and Q14, USP <1220>/<1225>/<1226>, ICH M10 bioanalytical, CLSI EP, or ISO/IEC 17025. Use for HPLC, LC-MS/MS, GC, CE, ICP-MS, dissolution, qNMR, qPCR, NIR, and ligand binding or cell-based assays whenever the question is whether a procedure is fit for its intended purpose. Triggers include "method validation", "analytical method validation", "AMV", "validation protocol", "acceptance criteria", "linearity", "reportable range", "accuracy and precision", "repeatability", "intermediate precision", "recovery", "LOD", "LOQ", "detection limit", "quantitation limit", "specificity", "robustness", "method transfer", "method comparison", "Deming", "Passing-Bablok", "Bland-Altman", "equivalence testing", "OOS investigation", "ICH Q2", "Q2(R2)", "Q14", "USP 1225", "ICH M10", "incurred sample reanalysis", "ISR", "CLSI EP", and any request to show that an assay works.
日本語の概要は準備中です。原文の説明を表示しています。
Comprehensive, measurement-driven performance optimization for latency, throughput, memory/GC, and tail behavior. Use when the user asks to optimize/speed up, reduce latency (p95/p99), increase throughput/QPS, lower CPU/memory/allocations/GC pauses, profile hot paths, or run a benchmarked perf pass (including JSONL/query-heavy code). Requires before/after measurement on a runnable workload (or an explicit `UNMEASURED` plan) plus a correctness gate.
日本語の概要は準備中です。原文の説明を表示しています。
Plan, execute, and document validation, verification, and transfer of analytical procedures under the governing framework - ICH Q2(R2) and Q14, USP <1220>/<1225>/<1226>, ICH M10 bioanalytical, CLSI EP, or ISO/IEC 17025. Use for HPLC, LC-MS/MS, GC, CE, ICP-MS, dissolution, qNMR, qPCR, NIR, and ligand binding or cell-based assays whenever the question is whether a procedure is fit for its intended purpose. Triggers include "method validation", "analytical method validation", "AMV", "validation protocol", "acceptance criteria", "linearity", "reportable range", "accuracy and precision", "repeatability", "intermediate precision", "recovery", "LOD", "LOQ", "detection limit", "quantitation limit", "specificity", "robustness", "method transfer", "method comparison", "Deming", "Passing-Bablok", "Bland-Altman", "equivalence testing", "OOS investigation", "ICH Q2", "Q2(R2)", "Q14", "USP 1225", "ICH M10", "incurred sample reanalysis", "ISR", "CLSI EP", and any request to show that an assay works.
日本語の概要は準備中です。原文の説明を表示しています。
Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.
日本語の概要は準備中です。原文の説明を表示しています。
Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.
日本語の概要は準備中です。原文の説明を表示しています。
Implementa e valida dados estruturados schema.org em JSON-LD — Organization, Article, FAQPage, Product, BreadcrumbList. Use quando o usuário disser "schema", "dados estruturados", "JSON-LD", "rich snippet", "FAQ schema", "schema.org".
日本語の概要は準備中です。原文の説明を表示しています。
Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.
日本語の概要は準備中です。原文の説明を表示しています。
Download and manage abqpy API documentation. Use when user asks about API documentation, API reference, or downloading Abaqus docs.
日本語の概要は準備中です。原文の説明を表示しています。